Biological variation estimates of Alzheimer’s disease plasma biomarkers in healthy individuals
Wagner S. Brum(Universidade Federal do Rio Grande do Sul), Kaj Blennow(Sahlgrenska University Hospital), Joel Simrén(University of Gothenburg), Eduardo R. Zimmer(Universidade Federal do Rio Grande do Sul), Juan Lantero‐Rodriguez(University of Gothenburg), Jorge Díaz–Garzón(Hospital Universitario La Paz), Aasne K. Aarsand(Haukeland University Hospital), Pilar Fernández–Calle(Hospital Universitario La Paz), Andréa Lessa Benedet(University of Pittsburgh), Sverre Sandberg(University of Bergen), William A. Bartlett(University of Dundee), Anna Carobene(IRCCS Ospedale San Raffaele), Thomas K. Karikari(University of Pittsburgh), Laia Montoliu‐Gaya(Sahlgrenska University Hospital), Andreas Jeromin(Cohen Veterans Bioscience), Abdurrahman Coşkun(European Federation of Animal Science), Henrik Zetterberg(University of Wisconsin System), Guglielmo Di Molfetta(University of Gothenburg), Niels Jonker(European Federation of Animal Science), Nicholas J. Ashton(King's College London)
Cited by 10
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k